Transesophageal echocardiography risk factors for stroke in nonvalvular atrial fibrillation

Echocardiography

Volumn 17, Issue 4, 2000, Pages 365-372

  Fagan, Susan M ^a   Chan, Kwan Leung ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Nonvalvular atrial fibrillation; Risk factors; Stroke; Transesophageal echocardiography

Indexed keywords

ARTICLE; DIAGNOSTIC IMAGING; HEART ANEURYSM; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART ATRIUM THROMBOSIS; HEART FORAMEN OVALE; HIGH RISK POPULATION; HUMAN; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0034123527     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2000.tb01152.x     Document Type: Article

References (39)

1. 1. Kannel WB, Wolf PA, Benjamin EJ, et al: Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol 1998;82:2N-9N.
2. 2. Kannel WB, Abbott RD, Savage DD, et al: Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982;306:1018-1022.
3. 3. Lin HJ, Wolf PA, Kelly-Hayes M, et al: Stroke severity in atrial fibrillation: The Framingham Study. Stroke 1996;27:1760-1764.
4. 4. The Stroke Prevention in Atrial Fibrillation Investigators: Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 1992;116:1-5.
5. 5. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
6. 6. Zabalgoitia M, Halperin JL, Pearce LA, et al: Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation: Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol 1998;31:1622-1626.
7. 7. Petersen P, Boysen G, Godtfredsen J, et al: Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study. Lancet 1989; 1:175-179.
8. 8. Ezekowitz MD, Bridgers SL, James KE, et al: Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation: Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992;327:1406-1412.
9. 9. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators: The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
10. 10. Connolly SJ, Laupacis A, Gent M, et al: Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-355.
11. 11. Castello R, Pearson AC, Labovitz AJ: Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography. Am J Cardiol 1990;65:1149-1153.
12. 12. Jones EF, Calafiore P, McNeil JJ, et al: Atrial fibrillation with left atrial spontaneous contrast detected by transesophageal echocardiography is a potent risk factor for stroke. Am J Cardiol 1996;78:425-429.
13. 13. Archer SL, James KE, Kvernen LR, et al: Role of transesophageal echocardiography in the detection of left atrial thrombus in patients with chronic nonrheumatic atrial fibrillation. Am Heart J 1995;130:287-295.
14. 14. Stollberger C, Chnupa P, Kronik G, et al: Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation: ELAT Study Group Embolism in Left Atrial Thrombi. Ann Intern Med 1998;128:630-638.
15. 15. Leung DY, Davidson PM, Cranney GB, et al: Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiogram. Am J Cardiol 1997;79:626-629.
16. 16. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography: Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998;128:639-647.
17. 17. Stroke Prevention in Atrial Fibrillation III Randomised Clinical Trial: Adjusted-dose: Warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation. Lancet 1996;348:633-638.
18. 18. Stoddard MF, Dawkins PR, Prince CR, et al: Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol 1995;25:452-459.
19. 19. Fatkin D, Kelly RP, Feneley MP: Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994;23:961-969.
20. 20. Manning WJ, Silverman DI, Keighley CS, et al: Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5-year study. J Am Coll Cardiol 1995;25:1354-1361.
21. 21. Black IW, Chesterman CN, Hopkins AP, et al: Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol 1993;21:451-457.
22. 22. Jones EF, Kaiman JM, Calafiore P, et al: Proximal aortic atheroma: An independent risk factor for cerebral ischemia. Stroke 1995;26:218-224.
23. 23. Amarenco P, Duyckaerts C, Tzourio C, et al: The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992;326:221-225.
24. 24. Amarenco P, Cohen A, Tzourio C, et al: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331: 1474-1479.
25. 25. Karalis DG, Chandrasekaran K, Victor MF, et al: Recognition and embolic potential of intraaortic atherosclerotic debris. J Am Coll Cardial 1991;17:73-78.
26. 26. Movsowitz C, Movsowitz HD, Jacobs LE, et al: Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography. J Am Soc Echocardiogr 1993;6:107-114.
27. 27. Blackshear JL, Pearce LA, Asinger RW, et al: Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation: Stroke Prevention in Atrial Fibrillation Investigators. Am J Cardiol 1993;72:840-843.
28. 28. Neilson GH, Galea EG, Hossack KF: Thromboembolic complications of mitral valve disease. Aust N Z J Med 1978;8:372-376.
29. 29. Davison G, Greenland P: Predictors of left atrial thrombus in mitral valve disease. J Gen Intern Med 1991;6:108-112.
30. 30. Hart RG, Miller VT: Cerebral infarction in young adults: A practical approach. Stroke 1983;14:110-114.
31. 31. Jones HRJ, Caplan LR, Come PC, et al: Cerebral emboli of paradoxical origin. Ann Neurol 1983;13:314-319.
32. 32. Lechat P, Mas JL, Lascault G, et al: Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
33. 33. Lynch JJ, Schuchard GH, Gross CM, et al: Prevalence of right-to-left atrial shunting in a healthy population: Detection by Valsalva maneuver contrast echocardiography. Am J Cardiol 1984;53:1478-1480.
34. 34. Fisher DC, Fisher EA, Budd JH, et al: The incidence of patent foramen ovale in 1,000 consecutive patients: A contrast transesophageal echocardiography study. Chest 1995;107:1504-1509.
35. 35. Hagen FT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
36. 36. Silver MD, Dorsey JS: Aneurysms of the septum primum in adults. Arch Pathol Lab Med 1978;102:62-65.
37. 37. Hanley PC, Tajik AJ, Hynes JK, et al: Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: Report of 80 consecutive cases. J Am Coll Cardiol 1985;6:1370-1382.
38. 38. Pearson AC, Nagelhout D, Castello R, et al: Atrial septal aneurysm and stroke: A transesophageal echocardiographic study. J Am Coll Cardiol 1991;18:1223-1229.
39. 39. Daniel WG, Nellessen U, Schroder E, et al: Left atrial spontaneous echo contrast in mitral valve disease: An indicator for an increased thromboembolic risk. J Am Coll Cardiol 1988; 11:1204-1211